Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Show Therapeutic Classes
Legacy Hazardous Drugs Do Not Tube List
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

emtricitabine/rilpivirine/tenofovir

emtricitabine/rilpivirine/tenofovir
Drug Name Form Strength Notes
Complera (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) TABLET, ORAL 200 mg-25 mg-300 mg
Odefsey emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide) TABLET, ORAL 200 mg-25 mg-25 mg
VIEW MORE HIV Nonnucleoside Reverse Transcriptase Inhibitors, HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
CLASS
08180816, 08180820
Additional Information:

NON-formulary medication

Last updated: Feb. 24, 2023






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved